Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Freshworks Reports Third Quarter 2022 Results

Published

on

  • Third quarter revenue grew 33% year-over-year, 37% adjusting for constant currency
  • Raises guidance for full year 2022 non-GAAP operating loss

SAN MATEO, Calif. , Nov. 01, 2022 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH), a leading software company empowering businesses to delight their customers and employees, today announced financial results for its third quarter ended September 30, 2022.

“We delivered a strong quarter of results with revenue up 37% on a constant currency basis and significantly improved our operating efficiency,“ said Girish Mathrubootham, CEO and founder of Freshworks. “In Q3, we continued to deliver on our promise of modern, powerful, easy to use software for everyone with new updates to our product suite.”

Third Quarter 2022 Financial Summary Results

  • Revenue: Total revenue was $128.8 million, representing growth of 33% compared to the third quarter of 2021 and 37% adjusting for constant currency.
  • GAAP (Loss) from Operations: GAAP (loss) from operations was $(58.3) million, compared to $(140.3) million in the third quarter of 2021.
  • Non-GAAP (Loss) from Operations: Non-GAAP (loss) from operations was $(3.1) million, compared to $(1.5) million in the third quarter of 2021.
  • GAAP Net (Loss) Per Share: GAAP basic and diluted net (loss) per share was $(0.20) based on 286.7 million weighted-average shares outstanding, compared to $(24.72) based on 95.9 million weighted-average shares outstanding in the third quarter of 2021.
  • Non-GAAP Net (Loss) Per Share: Non-GAAP basic and diluted net (loss) per share was $(0.01) based on 286.7 million weighted-average shares outstanding, compared to $(0.04) based on 95.9 million weighted-average shares outstanding in the third quarter of 2021.
  • Net Cash (Used in) Provided by Operating Activities: Net cash (used in) operating activities was $(4.2) million, compared to net cash (used in) operating activities of $(2.0) million in the third quarter of 2021.
  • Free Cash Flow: Free cash flow was $(7.2) million, compared to $(4.2) million in the third quarter of 2021.
  • Cash, Cash Equivalents and Marketable Securities: Cash, cash equivalents, and marketable securities were $1.2 billion as of September 30, 2022.

A description of non-GAAP financial measures is contained in the section titled “Explanation of Non-GAAP Financial Measures” below and a reconciliation of GAAP to non-GAAP financial measures is contained in the tables below.

Third Quarter Key Metrics and Recent Business Highlights

  • Number of customers contributing more than $5,000 in ARR was 16,713, an increase of 19% year-over-year and 23% adjusting for constant currency.
  • Net dollar retention rate was 107% and 113% adjusting for constant currency, compared to 111% in the second quarter of 2022 and 117% in the third quarter of 2021.
  • Welcomed new customers to the Freshworks community including: Altasciences, Clark College, Dwyer Instruments LLC, Dynata, HelloFresh, Media.Monks, Plume, Viessmann, and more.
  • Appointed Dennis Woodside as President and member of our Board of Directors.
  • Announced Freshservice for Business Teams to extend IT service management solutions to non-IT departments.
  • Enhanced Freshchat with AI-powered suggestion functionality to help agents improve response time.
  • Added real time lead scoring by embedding artificial intelligence within Freshsales and Freshmarketer.
  • Held our first Global Developer Summit for customers building on the Freshworks Neo Platform.

Financial Outlook

We are providing estimates for the fourth quarter and full year 2022 based on current market conditions and expectations. The revenue growth rates are only adjusted for constant currency to provide better visibility into the underlying business trends. We emphasize that these estimates are subject to various important cautionary factors referenced in the section entitled “Forward-Looking Statements” below.

For the fourth quarter and full year 2022, we currently expect the following results:

($ in millions, except per share data) Fourth Quarter 2022 Full Year 2022
Revenue(1) $129.2 – $131.2 $494.0 – $496.0
Year-over-year growth 22% – 24% 33% – 34%
Adjusting for constant currency(2) 27% – 28% 36% – 37%
     
Non-GAAP loss from operations(1) ($10.5) – ($8.5) ($30.0) – ($28.0)
     
Non-GAAP net loss per share(3) ($0.05) – ($0.03) ($0.13) – ($0.11)

(1) Revenue and non-GAAP loss from operations are based on exchange rates as of October 28, 2022 for currencies other than USD.
(2) Revenue growth rates adjusted for constant currency are based on average exchange rates in effect during the comparison period for currencies other than USD. See the section entitled “Explanation of non-GAAP Financial Measures” and the table entitled “Reconciliation of Selected GAAP Measures to non‑GAAP Measures” for a reconciliation of GAAP to non‑GAAP measures.
(3) Non-GAAP net loss per share was estimated assuming 288.5 million and 284.6 million weighted-average shares outstanding for the fourth quarter and full year 2022, respectively.

These statements are forward-looking and actual results may differ materially. Refer to the “Forward-Looking Statements” safe harbor section below for information on the factors that could cause our actual results to differ materially from these forward-looking statements.

We have not reconciled our estimates for non-GAAP loss from operations to GAAP loss from operations or non-GAAP net loss per share to GAAP net loss per share due to the uncertainty and potential variability of expenses that may be incurred in the future. Accordingly, a reconciliation is not available without unreasonable effort. We have provided a reconciliation of other GAAP to non-GAAP financial measures in the financial statement tables for our third quarter 2022 non-GAAP results included in this press release.

Webcast and Conference Call Information

We will host a conference call for investors on November 1, 2022 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss the company’s financial results and business highlights. Investors are invited to listen to a live audio webcast of the conference call by visiting the investor relations website at ir.freshworks.com. A replay of the audio webcast will be available shortly after the call on the Freshworks Investor Relations website and will be available for twelve months thereafter.

Explanation of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), this press release and the accompanying tables contain non-GAAP financial measures, including revenue and revenue growth rates adjusted for constant currency, non-GAAP gross profit, non-GAAP gross margin, non-GAAP sales and marketing expense, non-GAAP research and development expense, non-GAAP general and administrative expense, non-GAAP loss from operations, non-GAAP operating margin, non-GAAP net loss per share, non-GAAP net loss attributable to common stockholders, and free cash flow. The presentation of these financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP.

We adjust revenue and related growth rates for constant currency to provide a framework for assessing business performance excluding the effect of foreign currency rate fluctuations. To present this information, current period results for currencies other than USD are converted into USD at the average exchange rates in effect during the comparison period (for Q3 2021, the average exchange rates in effect for our major currencies were 1 USD to 1.18 EUR and 1 USD to 1.38 GBP), rather than the actual average exchange rates in effect during the current period (for Q3 2022, the average exchange rates in effect for our major currencies were 1 USD to 1.01 EUR and 1 USD to 1.18 GBP).

We use these non-GAAP measures in conjunction with GAAP measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies and to communicate with our board of directors concerning our financial performance. We believe these non-GAAP measures provide investors consistency and comparability with our past financial performance and facilitate period-to-period comparisons of our operating results. We believe these non-GAAP measures are useful in evaluating our operating performance compared to that of other companies in our industry, as they generally eliminate the effects of certain items that may vary for different companies for reasons unrelated to overall operating performance.

Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. The non-GAAP measures we use may be different from non-GAAP financial measures used by other companies, limiting their usefulness for comparison purposes. We compensate for these limitations by providing specific information regarding the GAAP items excluded from these non-GAAP financial measures.

We exclude the following items from one or more of our non-GAAP financial measures, including the related income tax effect of these adjustments:

  • Stock-based compensation expense. We exclude stock-based compensation, which is a non-cash expense, from certain of our non-GAAP financial measures because we believe that excluding this expense provides meaningful supplemental information regarding operational performance. In particular, stock-based compensation expense is not comparable across companies given the variety of valuation methodologies and assumptions.
  • Employer payroll taxes on employee stock transactions. We exclude the amount of employer payroll taxes on equity awards from certain of our non-GAAP financial measures because they are dependent on our stock price at the time of vesting or exercise and other factors that are beyond our control and do not believe these expenses have a direct correlation to the operation of our business.
  • Amortization of acquired intangibles. We exclude amortization of acquired intangibles, which is a non-cash expense, from certain of our non-GAAP financial measures. Our expenses for amortization of acquired intangibles are inconsistent in amount and frequency because they are significantly affected by the timing, size of acquisitions, and the allocation of purchase price. We exclude these amortization expenses because we do not believe these expenses have a direct correlation to the operation of our business.
  • Gain on sale of non-marketable equity investments. We exclude gains on sale of non-marketable equity investments from certain of our non-GAAP financial measures because we believe they are unrelated to our ongoing operating performance and are not expected to recur in our continuing operating results.

We define free cash flow as net cash provided by operating activities, less purchases of property and equipment and capitalized internal-use software. We believe that free cash flow is a useful indicator of liquidity as it measures our ability to generate cash from our core operations after purchases of property and equipment. Free cash flow is a measure to determine, among other things, cash available for strategic initiatives, including further investments in our business and potential acquisitions of businesses.

Operating Metrics

Number of Customers Contributing More Than $5,000 in ARR. We define ARR as the sum total of the revenue we would contractually expect to recognize over the next 12 months from all customers at a point in time, assuming no increases, reductions or cancellations in their subscriptions. We define our total customers contributing more than $5,000 in ARR as of a particular date as the number of business entities or individuals, represented by a unique domain or a unique email address, with one or more paid subscriptions to one or more of our products that contributed more than $5,000 in ARR.

Net Dollar Retention Rate. To calculate net dollar retention rate as of a given date, we first determine Entering ARR, which is ARR from the population of our customers as of 12 months prior to the end of the reporting period. We then calculate the Ending ARR from the same set of customers as of the end of the reporting period. We then divide the Ending ARR by the Entering ARR to arrive at our net dollar retention rate. Ending ARR includes upsells, cross-sells, and renewals during the measurement period and is net of any contraction or attrition over this period.

We also adjust the above operating metrics and related growth rates for constant currency to provide a framework for assessing our business performance excluding the effects of foreign currency rates fluctuations. To present this information, the Ending ARR of the current period in currencies other than USD is converted into USD at the exchange rates in effect at the end of the comparison period (for Q3 2021, the period end exchange rates in effect for our major currencies were 1 USD to 1.16 EUR and 1 USD to 1.35 GBP), rather than the actual exchange rates in effect at the end of the current period (for Q3 2022, the period end exchange rates in effect for our major currencies were 1 USD to 0.98 EUR and 1 USD to 1.12 GBP).

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, our GAAP and non-GAAP estimates for the fourth quarter and full year 2022, our financial outlook, the value of our products to customers, our ability to drive long-term growth, and the usefulness of the measures by which we evaluate our business, among other things. These forward-looking statements are based on our current expectations, estimates and projections about its business and industry, management’s beliefs and certain assumptions made by the company, all of which are subject to change. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “future”, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” “anticipate,” “could,” “would,” “projects,” “plans,” “targets” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, many of which involve factors or circumstances that are beyond our control, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. Factors that may cause actual results to differ materially include our ability to achieve our long-term plans and key initiatives; our ability to sustain or manage any future growth effectively; our ability to attract and retain customers or expand sales to existing customers; delays in product development or deployments or the success of such products; the failure to deliver competitive service offerings and lack of market acceptance of any offerings delivered; the impact to the economy, our customers and our business due to global economic conditions, including market volatility, foreign exchange rates, and impact of inflation; the timeframes for and severity of the impact of any weakened global economic conditions on our customers’ purchasing and renewal decisions, which may extend the length of our sales cycles or adversely affect our industry; our history of net losses and ability to achieve or sustain profitability, as well as the other potential factors described under “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2021 and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022, and other documents of Freshworks Inc. we file with the Securities and Exchange Commission from time to time (available at www.sec.gov), including our Quarterly Report on Form 10-Q that will be filed for the quarter ended September 30, 2022.

We caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof and are based on information available to us at the time the statements are made and/or management’s good faith belief as of that time with respect to future events. We assume no obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release, except as required by law.

About Freshworks Inc.

Freshworks Inc., (NASDAQ: FRSH) makes business software people love to use. Purpose-built for IT, customer support, and sales and marketing teams, our products empower the people who power business. Freshworks is fast to onboard, priced affordably, built to delight, yet powerful enough to deliver critical business outcomes. Headquartered in San Mateo, California, Freshworks operates around the world to serve more than 60,000 customers including Allbirds, Blue Nile, Bridgestone, Databricks, Klarna, NHS, OfficeMax, and PhonePe. For the freshest company news visit www.freshworks.com and follow us on Facebook, LinkedIn and Twitter.

Investor Relations Contact:
Joon Huh
[email protected]
650-988-5699

Media Relations Contact:
Jayne Gonzalez
[email protected]
408-348-1087

© 2022 Freshworks Inc. All Rights Reserved. Freshworks and its associated logo is a trademark of Freshworks Inc. All other company, brand and product names may be trademarks or registered trademarks of their respective companies. Nothing in this press release should be construed to the contrary, or as an approval, endorsement or sponsorship by any first parties of Freshworks Inc. or any aspect of this press release.

FRESHWORKS INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)

  Three Months Ended
September 30,
  Nine Months Ended
September 30,
    2022       2021       2022       2021  
Revenue $ 128,760     $ 96,614     $ 364,829     $ 265,542  
Cost of revenue(1)   24,179       22,236       70,616       57,632  
Gross profit   104,581       74,378       294,213       207,910  
Operating expense:              
Research and development(1)   35,871       57,087       100,885       91,377  
Sales and marketing(1)   86,865       96,785       248,369       188,155  
General and administrative(1)   40,133       60,759       117,723       76,785  
Total operating expenses   162,869       214,631       466,977       356,317  
Loss from operations   (58,288 )     (140,253 )     (172,764 )     (148,407 )
Interest and other income, net   2,249       22,923       2,609       23,428  
Loss before income taxes   (56,039 )     (117,330 )     (170,155 )     (124,979 )
Provision for (benefit from) income taxes   1,804       (9,915 )     6,500       (7,720 )
Net loss   (57,843 )     (107,415 )     (176,655 )     (117,259 )
Accretion of redeemable convertible preferred stock         (2,264,838 )           (2,646,662 )
Net loss attributable to common stockholders $ (57,843 )   $ (2,372,253 )   $ (176,655 )   $ (2,763,921 )
Net loss per share attributable to common stockholders – basic and diluted $ (0.20 )   $ (24.72 )   $ (0.62 )   $ (32.96 )
Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted   286,697       95,930       283,258       83,860  

______________________
(1)        Includes stock-based compensation expense as follows (in thousands):

  Three Months Ended
September 30,
  Nine Months Ended
September 30,
    2022     2021     2022     2021
Cost of revenue $ 1,772   $ 3,983   $ 5,212   $ 3,983
Research and development   10,318     36,823     26,446     36,823
Sales and marketing   16,635     40,465     44,204     40,465
General and administrative   25,167     42,988     74,790     42,988
Total stock-based compensation expense $ 53,892   $ 124,259   $ 150,652   $ 124,259

FRESHWORKS INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)

    September 30,
2022
  December 31, 2021
    (unaudited)    
Assets        
Current assets:        
Cash and cash equivalents   $ 432,313     $ 747,861  
Marketable securities     719,218       575,679  
Accounts receivable, net     56,835       51,756  
Deferred contract acquisition costs     18,282       14,640  
Prepaid expenses and other current assets     42,431       31,440  
Total current assets     1,269,079       1,421,376  
Property and equipment, net     23,381       21,478  
Operating lease right-of-use assets     28,821        
Deferred contract acquisition costs, noncurrent     17,598       15,007  
Intangible assets, net     579       1,894  
Goodwill     6,181       6,181  
Deferred tax assets     5,396       6,284  
Other assets     12,050       10,592  
Total assets   $ 1,363,085     $ 1,482,812  
Liabilities and Stockholders’ Equity        
Current liabilities:        
Accounts payable   $ 3,873     $ 6,321  
Accrued liabilities     57,447       55,829  
Deferred revenue     190,969       160,173  
Income tax payable     65       1,023  
Total current liabilities     252,354       223,346  
Operating lease liabilities, non-current     24,630        
Other liabilities     26,098       21,427  
Total liabilities     303,082       244,773  
Stockholders’ equity:        
Common stock     3       3  
Additional paid-in capital     4,516,386       4,509,724  
Accumulated other comprehensive loss     (8,790 )     (747 )
Accumulated deficit     (3,447,596 )     (3,270,941 )
Total stockholders’ equity     1,060,003       1,238,039  
Total liabilities and stockholders’ equity   $ 1,363,085     $ 1,482,812  

FRESHWORKS INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)

  Three Months Ended
September 30,
  Nine Months Ended
September 30,
    2022       2021       2022       2021  
Cash Flows from Operating Activities:              
Net loss $ (57,843 )   $ (107,415 )   $ (176,655 )   $ (117,259 )
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:              
Depreciation and amortization   2,795       3,374       8,574       9,792  
Amortization of deferred contract acquisition costs   4,625       3,416       13,321       9,085  
Non-cash lease expense   1,567             4,463        
Stock-based compensation   53,892       124,259       150,652       124,259  
Premium amortization on marketable securities   (533 )     411       564       1,206  
Gain realized on sale of marketable securities and non-marketable equity investments         (23,821 )           (23,835 )
Change in fair value of equity securities   10       (35 )     (75 )     (100 )
Deferred income taxes         (11,721 )     309       (11,721 )
Other   273       69       1,468       133  
Changes in operating assets and liabilities:              
Accounts receivable   (1,432 )     (3,929 )     (5,256 )     (10,039 )
Deferred contract acquisition costs   (6,913 )     (6,032 )     (19,554 )     (17,032 )
Prepaid expenses and other assets   (3,929 )     (12,963 )     (12,374 )     (14,823 )
Accounts payable   (2,416 )     (4,513 )     (1,962 )     (542 )
Accrued and other liabilities   668       24,193       3,874       18,517  
Deferred revenue   8,173       12,661       30,796       38,975  
Operating lease liabilities   (3,160 )           (7,837 )      
Net cash (used in) provided by operating activities   (4,223 )     (2,046 )     (9,692 )     6,616  
Cash Flows from Investing Activities:              
Purchases of property and equipment   (1,907 )     (1,270 )     (5,288 )     (4,056 )
Proceeds from sale of property and equipment   49       8       132       565  
Capitalized internal-use software   (1,106 )     (873 )     (3,828 )     (3,050 )
Sale of non-marketable equity investments         23,979             23,979  
Purchases of marketable securities   (250,301 )     (43,988 )     (538,501 )     (154,828 )
Sales of marketable securities         2,076       92,786       36,831  
Maturities and redemptions of marketable securities   113,055       30,750       293,625       112,554  
Net cash (used in) provided by investing activities   (140,210 )     10,682       (161,074 )     11,995  
Cash Flows from Financing Activities:              
Proceeds from initial public offering, net of underwriting discounts         1,069,348             1,069,348  
Proceeds from issuance of common stock under employee stock purchase plan, net               7,011        
Proceeds from exercise of stock options   2       12       98       43  
Payment of withholding taxes on net share settlement of equity awards   (13,367 )           (151,716 )      
Payment of deferred offering costs         (3,067 )     (109 )     (5,472 )
Payment of acquisition-related liabilities         (900 )           (900 )
Net cash (used in) provided by financing activities   (13,365 )     1,065,393       (144,716 )     1,063,019  
               
Net (decrease) increase in cash, cash equivalents and restricted cash   (157,798 )     1,074,029       (315,482 )     1,081,630  
Cash, cash equivalents and restricted cash, beginning of period   590,180       105,932       747,864       98,331  
Cash, cash equivalents and restricted cash, end of period $ 432,382     $ 1,179,961     $ 432,382     $ 1,179,961  

FRESHWORKS INC.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(in thousands, except percentages and per share data)
(unaudited)

    Three Months Ended
September 30,
   
      2022     2021   Growth Rates
Revenue            
GAAP revenue   $ 128,760   $ 96,614   33 %
Effects of foreign currency rate fluctuations     3,428        
Revenue adjusted for constant currency   $ 132,188       37 %

FRESHWORKS INC.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(in thousands, except percentages and per share data)
(unaudited)

    Three Months Ended
September 30,
  Nine Months Ended
September 30,
      2022       2021       2022       2021  
Reconciliation of gross profit and gross margin:                
GAAP gross profit   $ 104,581     $ 74,378     $ 294,213     $ 207,910  
Non-GAAP adjustments:                
Stock-based compensation expense     1,772       3,983       5,212       3,983  
Employer payroll taxes on employee stock transactions     58       523       25       523  
Amortization of acquired intangibles     175       990       1,015       2,939  
Non-GAAP gross profit   $ 106,586     $ 79,874     $ 300,465     $ 215,355  
GAAP gross margin     81.2 %     77.0 %     80.6 %     78.3 %
Non-GAAP gross margin     82.8 %     82.7 %     82.4 %     81.1 %
                 
Reconciliation of operating expenses:                
GAAP research and development   $ 35,871     $ 57,087     $ 100,885     $ 91,377  
Non-GAAP adjustments:                
Stock-based compensation expense     (10,318 )     (36,823 )     (26,446 )     (36,823 )
Employer payroll taxes on employee stock transactions     (25 )     (1,632 )     127       (1,632 )
Non-GAAP research and development   $ 25,528     $ 18,632     $ 74,566     $ 52,922  
GAAP research and development as percentage of revenue     27.9 %     59.1 %     27.7 %     34.4 %
Non-GAAP research and development as percentage of revenue     19.8 %     19.3 %     20.4 %     19.9 %
                 
GAAP sales and marketing   $ 86,865     $ 96,785     $ 248,369     $ 188,155  
Non-GAAP adjustments:                
Stock-based compensation expense     (16,635 )     (40,465 )     (44,204 )     (40,465 )
Employer payroll taxes on employee stock transactions     (746 )     (4,409 )     (954 )     (4,409 )
Amortization of acquired intangibles     (101 )     (101 )     (300 )     (299 )
Non-GAAP sales and marketing   $ 69,383     $ 51,810     $ 202,911     $ 142,982  
GAAP sales and marketing as percentage of revenue     67.5 %     100.2 %     68.1 %     70.9 %
Non-GAAP sales and marketing as percentage of revenue     53.9 %     53.6 %     55.6 %     53.8 %
                 
GAAP general and administrative   $ 40,133     $ 60,759     $ 117,723     $ 76,785  
Non-GAAP adjustments:                
Stock-based compensation expense     (25,167 )     (42,988 )     (74,790 )     (42,988 )
Employer payroll taxes on employee stock transactions     (165 )     (6,815 )     (457 )     (6,815 )
Non-GAAP general and administrative   $ 14,801     $ 10,956     $ 42,476     $ 26,982  
                 
GAAP general and administrative as percentage of revenue     31.2 %     62.9 %     32.3 %     28.9 %
Non-GAAP general and administrative as percentage of revenue     11.5 %     11.3 %     11.6 %     10.2 %
                 
Reconciliation of operating loss and operating margin:                
GAAP loss from operations   $ (58,288 )   $ (140,253 )   $ (172,764 )   $ (148,407 )
Non-GAAP adjustments:                
Stock-based compensation expense     53,892       124,259       150,652       124,259  
Employer payroll taxes on employee stock transactions     994       13,379       1,309       13,379  
Amortization of acquired intangibles     276       1,091       1,315       3,238  
Non-GAAP loss from operations   $ (3,126 )   $ (1,524 )   $ (19,488 )   $ (7,531 )
GAAP operating margin   (45.3)        %   (145.2)        %   (47.4)        %   (55.9)        %
Non-GAAP operating margin   (2.4)        %   (1.6)        %   (5.3)        %   (2.8)        %
                 
Reconciliation of net loss attributable to common stockholders:                
GAAP net loss attributable to common stockholders – basic and diluted   $ (57,843 )   $ (2,372,253 )   $ (176,655 )   $ (2,763,921 )
Non-GAAP adjustments:                
Accretion of redeemable convertible preferred stock           2,264,838             2,646,662  
Stock-based compensation expense     53,892       124,259       150,652       124,259  
Employer payroll taxes on employee stock transactions     994       13,379       1,309       13,379  
Amortization of acquired intangibles     276       1,091       1,315       3,238  
Gain on sale of non-marketable equity investments           (23,830 )           (23,830 )
Income tax adjustments     565       (11,555 )     1,528       (11,555 )
Non-GAAP net loss attributable to common stockholders – basic and diluted   $ (2,116 )   $ (4,071 )   $ (21,851 )   $ (11,768 )
                 
Reconciliation of net loss per share – basic and diluted:                
GAAP net loss per share attributable to common stockholders – basic and diluted   $ (0.20 )   $ (24.72 )   $ (0.62 )   $ (32.96 )
Non-GAAP adjustments:                
Accretion of redeemable convertible preferred stock           23.61             31.56  
Stock-based compensation expense     0.19       1.29       0.53       1.48  
Employer payroll taxes on employee stock transactions           0.14             0.16  
Amortization of acquired intangibles           0.01             0.04  
Gain on sale of non-marketable equity investments           (0.25 )           (0.28 )
Income tax adjustments           (0.12 )     0.01       (0.14 )
Non-GAAP net loss per share attributable to common stockholders – basic and diluted   $ (0.01 )   $ (0.04 )   $ (0.08 )   $ (0.14 )
Weighted-average shares used in computing GAAP and non-GAAP net loss per share attributable to common stockholders – basic and diluted     286,697       95,930       283,258       83,860  
                 
Computation of free cash flow:                
Net cash (used in) provided by operating activities   $ (4,223 )   $ (2,046 )   $ (9,692 )   $ 6,616  
Less:                
Purchases of property and equipment     (1,907 )     (1,270 )     (5,288 )     (4,056 )
Capitalized internal-use software     (1,106 )     (873 )     (3,828 )     (3,050 )
Free cash flow   $ (7,236 )   $ (4,189 )   $ (18,808 )   $ (490 )
Net cash provided by (used in) investing activities   $ (140,210 )   $ 10,682     $ (161,074 )   $ 11,995  
Net cash provided by (used in) financing activities   $ (13,365 )   $ 1,065,393     $ (144,716 )   $ 1,063,019  

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Department of Health – Abu Dhabi Unveils ‘Declaration of Principles’ on Bioconvergence to Enhance Global Healthcare Outcomes

Published

on

department-of-health-–-abu-dhabi-unveils-‘declaration-of-principles’-on-bioconvergence-to-enhance-global-healthcare-outcomes

ABU DHABI, UAE, May 13, 2024 /PRNewswire/ — An an outcome of the Health Leaders Forum (HLF) organised during Abu Dhabi Global Healthcare Week (ADGHW), the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, unveiled a Declaration of Principles on Bioconvergence, to transform healthcare, improve human health and well-being. As a first-of-its-kind initiative, the Declaration outlines global principles covering guidance on transparency, accountability, and bias mitigation, as well as research ethics and ethical decision-making in the field of Bioconvergence.

Bioconvergence has been recognised as the latest technological trend of the 21st century for the healthcare sector. It is a transdisciplinary field that merges engineering and life sciences, and is set to revolutionise the health-tech industry. Bioconvergence fuses life sciences with a vast number of technologies from fields such as mathematics, engineering, and physical and computational sciences.
The Declaration of Principles will witness leading local and global entities collaborate with DoH including Amazon, Microsoft, UAE University (UAEU), Mohammad Bin Zayed University for AI (MBZUAI), Core 42 and Masdar City. Segmented into six strategic pillars, the principles aim to advance Bioconvergence research and development, encourage investment in the field to address urgent healthcare challenges, establish international cooperation frameworks, prioritise research areas in public health and personalised medicine, and promote the adoption of advanced technologies such as Artificial Intelligence (AI) and nanomedicine.
Dr. Asma Ibrahim Al Mannaei, the Executive Director of the Research and Innovation Centre at the Department of Health – Abu Dhabi (DoH): “In the intricacies of Bioconvergence, establishing fundamental principles is not merely a choice, but a collective responsibility. These principles serve as a beacon of transparency, guardians of accountability and shields against any form of bias. With the ever-evolving intersection of health and technology, integrity and diligence remain guiding threads for the Department of Health – Abu Dhabi. Reinforcing Abu Dhabi’s position as a leading destination for innovation in healthcare, the unique Declaration serves as a testament to the Department’s continued efforts to build a healthier world and shape the future of healthcare for generations to come.”
Moreover, upholding ethical standards and responsible practices involve raising awareness on the benefits and risks of Bioconvergence technologies, establishing ethical guidelines, and ensuring accessibility and affordability for all. Investment in education and workforce development entails supporting skill development, integrating Bioconvergence into relevant curricula, fostering interdisciplinary collaboration, and promoting diversity in the field.
Additionally, fostering collaboration and the exchange of knowledge among stakeholders, advocating for supportive policies and regulations, and engaging the community through awareness campaigns and transparent communication are crucial steps in advancing Bioconvergence research and innovation while maintaining community’s trust and support. These key pillars will support accelerating the future of healthcare and life sciences by making quality health a global priority.
Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, Abu Dhabi Global Healthcare Week is a major government initiative taking place between 13 and 15 May 2024. ADGHW seeks to accelerate collaboration, innovation, and investment, and bring together researchers, policymakers, healthcare specialists, investors, and entrepreneurs across the global healthcare and life science ecosystem.
For more information please visit: https://www.adghw.com/
About Department of Health – Abu Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system.
For further information on DoH, visit https://www.doh.gov.ae/ and follow on X, Instagram, Facebook, LinkedIn and YouTube.
Photo – https://mma.prnewswire.com/media/2411144/DoH_Abu_Dhabi.jpg

View original content:https://www.prnewswire.co.uk/news-releases/department-of-health–abu-dhabi-unveils-declaration-of-principles-on-bioconvergence-to-enhance-global-healthcare-outcomes-302143829.html

Continue Reading

Artificial Intelligence

Advanced HPC Server Platforms by MiTAC and TYAN Spotlighted at ISC High Performance 2024

Published

on

advanced-hpc-server-platforms-by-mitac-and-tyan-spotlighted-at-isc-high-performance-2024

HAMBURG, Germany, May 13, 2024 /PRNewswire/ — Today, the subsidiary of MiTAC Holdings Corp.(TSE:3706), MiTAC Computing Technology and its server brand TYAN®, the leading manufacturer in server platform design worldwide, bring their new server platforms to the ISC 2024 event, booth #B01 in Hamburg, Germany. These solutions harness the power of the latest AMD EPYC 9004 series and AMD Ryzen 7000 series, along with the 5th Gen Intel Xeon Scalable Processors, offering optimized performance for HPC needs.

MiTAC introduces its revolutionary lineup of DSG products
Driven by shared values, MiTAC and Intel have had a strong partnership for years. Last year, MiTAC took over the manufacturing and sales of products designed by Intel Datacenter Solution Group (DSG). Today, MiTAC presents two models from its DSG product lineups, which are from the Intel Server M50FCP Family and the Intel Server D50DNP Family, at ISC 2024.
First, MiTAC displays a multi-node server, the Intel Server System D50DNP1MHEVAC 1U Half-Width air-cooled compute module with EVAC heatsink from the Intel Server D50DNP Family (Denali Pass). Intel® Server D50DNP family is the highest-performance density server featuring 5th/4th Gen Intel® Xeon® Scalable Processors or the Intel® Xeon® CPU Max Series and purpose-built modules, delivering robust performance, efficiency, and scalability tailored to specific needs for AI computing.
Then, there is the 1U Intel Server System M50FCP1UR204 from the Intel Server M50FCP Family (Fox Creek Pass). Supporting 5th/4th Gen Intel® Xeon® Scalable processors, the general purpose Intel® Server M50FCP Family offers robust compute capabilities, integrated accelerators, and exceptional I/O and memory bandwidth, making it the perfect solution for handling data-intensive mainstream tasks.
TYAN brings HPC optimized servers at ISC 2024
The Transport CX TD76-B8058 is a 2U 4-node single-socket HCI server powered by AMD EPYC 9004 processors. Each node includes 16 DDR5-4800 DIMM slots, 4 hot-swappable E1.s drive bays, 2 NVMe M.2 slots, 1 OCP v3.0 LAN mezzanine slot, and 1 standard PCIe 5.0 x16 slot. Front I/O facilitates efficient network cable routing, while rear-accessible hot-swappable cooling fans and redundant 80+ Titanium power supplies ensure optimal system serviceability.  Powered by 5th/4th Gen Intel Xeon Scalable processor, TYAN Thunder CX TD76-B5658 is a 2U 4 nodes single-socket server designed for high-density cloud server deployment. It comes with shared system fans, redundant 80+ Titanium power supplies, and hot-swappable modules for simple maintenance. Additionally, it offers front I/O for effortless network cable management, and each node supports PCIe 5.0 x16, OCP v3.0 LAN mezzanine, and NVMe E1.s SSDs.
Apart from the above, TYAN provides the Transport CX GX40-B8016 for those requiring entry-level servers. This compact 1U AMD Ryzen cloud server is perfect for front-end portal and edge computing tasks in data centers. It features 4 DDR5-4800 UDIMM slots, supports up to 4 SATA drives, 2 NVMe M.2 slots, and one PCIe 5.0 x16 slot.
About MiTAC Computing Technology Corp.
MiTAC Computing Technology Corp, a MiTAC Holdings Corp. (TSE:3706) subsidiary, specializes in cloud and edge computing solutions and has over 30 years of design and manufacturing expertise. With a strong focus on large-scale data centers, the company offers flexible and customized supply models for various systems and applications. Its product lineup includes TYAN servers, 5G ORAN servers, high-performance AI servers, and data center products. Intel Datacenter Solutions Group (DSG) transited its business to MiTAC since July 2023, allowing MiTAC expanding its product offerings with cutting-edge total cost of ownership solutions for next-gen data center equipment.
MiTAC Computing Technology Official website: www.mitacmct.com
MiTAC DSG website: https://datacentersolutions.mitacmct.com/
About TYAN
TYAN, as a leading server brand of MiTAC Computing Technology Corporation under the MiTAC Holdings Corp. (TSE:3706), designs, manufactures and markets advanced x86 and x86-64 server/workstation board technology, platforms and server solution products. Its products are sold to OEMs, VARs, System Integrators and Resellers worldwide for a wide range of applications. TYAN enables its customers to be technology leaders by providing scalable, highly-integrated, and reliable products for a wide range of applications such as server appliances and solutions for HPC, hyper-scale/data center, server storage, AI and security appliance markets. For more information, please visit TYAN’s website at http://www.tyan.com or MiTAC Computing Technology Corporation website at http://www.mitacmct.com
AMD, the AMD Arrow logo, EPYC, Ryzen and combinations thereof are trademarks of Advanced Micro Devices, Inc.
Intel, the Intel logo, Xeon and combinations thereof are trademarks of Intel Corporation
Photo – https://mma.prnewswire.com/media/2408826/2024_ISC_PR.jpg

View original content:https://www.prnewswire.co.uk/news-releases/advanced-hpc-server-platforms-by-mitac-and-tyan-spotlighted-at-isc-high-performance-2024-302141236.html

Continue Reading

Artificial Intelligence

Department of Health – Abu Dhabi partners with MBZUAI and Core42 to launch Global AI Healthcare Academy

Published

on

department-of-health-–-abu-dhabi-partners-with-mbzuai-and-core42-to-launch-global-ai-healthcare-academy

ABU DHABI, UAE, May 13, 2024 /PRNewswire/ — The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), the leading AI research-based academic institution located in Abu Dhabi, and Core42, a G42 company offering AI solutions, during Abu Dhabi Global Healthcare Week (ADGHW). This MoU will launch the global AI Healthcare Academy to the health workforce. The MoU was signed by Dr. Rashed Obaid Al Suwaidi, Executive Director of Healthcare Workforce Planning Sector at DoH, Sultan Al Hajji, Vice President of Public Affairs and Alumni Relations at MBZUAI and Talal Al Kaissi, Executive Vice President, Chief Product and Global Partnership Officer at Core42.

 
 
Reinforcing Abu Dhabi’s position as a leading destination for healthcare and life sciences, the partnership seeks to establish a framework of collaboration to strengthen the Emirate’s position at the forefront of technology-enabled and data-driven healthcare systems. The new AI Healthcare Academy will help to build a global AI-trained workforce, which is capable of advancing diagnostic and operational efficiency, significantly improving patient care, and streamlining healthcare processes around the world.
Sultan Al Hajji, Vice President of Public Affairs and Alumni Relations at MBZUAI, said: “Healthcare is a key research pillar for MBZUAI, because we recognise the transformative and life-saving potential of AI across a wide range of diagnostic and treatment areas. In addition to our recent effort in establishing the Institute of Digital Public Health, we are proud to partner with The Department of Health – Abu Dhabi in launching the new AI Healthcare Academy. MBZUAI will provide the Academy our world-class faculty to facilitate AI workshops and training to upskill the healthcare workforce in support of the UAE leadership’s vision to become a global hub for AI and a centre for life sciences.”
Through leveraging advanced technologies and harnessing the power of AI, DoH seeks to upskill the health workforce, enhance local practices and contribute to broader medical research and treatment modalities worldwide. By embracing AI-driven technologies, healthcare professionals can stay at the forefront of innovation, fostering collaboration and knowledge exchange on a global scale.
By collaborating with MBZUAI through its Institute of Digital Public Health, the Academy will encompass ground-breaking research. These efforts will encourage public-private partnerships, fostering collaboration to secure ample funding and ensure ongoing sustainability, setting the academy for long-term success and supporting responsible and impactful innovation.
Under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, Abu Dhabi Global Healthcare Week (ADGHW) is a major government initiative from DoH, taking place between 13 and 15 May 2024.
For more information please visit: https://www.adghw.com/
About Department of Health – Abu Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system.
For further information on DoH, visit https://www.doh.gov.ae/ and follow on X, Instagram, Facebook, LinkedIn and YouTube.
About Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)
MBZUAI is a graduate, research university focused on artificial intelligence, computer science, and digital technologies across industrial sectors. The university aims to empower students, businesses, and governments to advance artificial intelligence as a global force for positive progress. MBZUAI offers various graduate programs designed to pursue advanced, specialized knowledge and skills in artificial intelligence, including computer science, computer vision, machine learning, natural language processing, and robotics. For more information, please visit www.mbzuai.ac.ae.
Photo – https://mma.prnewswire.com/media/2411164/The_Department_of_Health_Abu_Dhabi.jpg

View original content:https://www.prnewswire.co.uk/news-releases/department-of-health–abu-dhabi-partners-with-mbzuai-and-core42-to-launch-global-ai-healthcare-academy-302143723.html

Continue Reading

Trending